FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 339:489-497 August 20, 1998 Number 8 Next

	Full Text PDF Editorial by Radford, M. J. Letters Letters Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Long-term administration of beta-adrenergic blockers to patients after myocardial infarction improves survival. However, physicians are reluctant to administer beta-blockers to many patients, such as older patients and those with chronic pulmonary disease, left ventricular dysfunction, or non–Q-wave myocardial infarction.

Methods The medical records of 201,752 patients with myocardial infarction were abstracted by the Cooperative Cardiovascular Project, which was sponsored by the Health Care Financing Administration. Using a Cox proportional-hazards model that accounted for multiple factors that might influence survival, we compared mortality among patients treated with beta-blockers with mortality among untreated patients during the two years after myocardial infarction.

Results A total of 34 percent of the patients received beta-blockers. The percentage was lower among the very elderly, blacks, and patients with the lowest ejection fractions, heart failure, chronic obstructive pulmonary disease, elevated serum creatinine concentrations, or type 1 diabetes mellitus. Nevertheless, mortality was lower in every subgroup of patients treated with beta-blockade than in untreated patients. In patients with myocardial infarction and no other complications, treatment with beta-blockers was associated with a 40 percent reduction in mortality. Mortality was also reduced by 40 percent in patients with non–Q-wave infarction and those with chronic obstructive pulmonary disease. Blacks, patients 80 years old or older, and those with a left ventricular ejection fraction below 20 percent, serum creatinine concentration greater than 1.4 mg per deciliter (124 µmol per liter), or diabetes mellitus had a lower percentage reduction in mortality. Given, however, the higher mortality rates in these subgroups, the absolute reduction in mortality was similar to or greater than that among patients with no specific risk factors.

Conclusions After myocardial infarction, patients with conditions that are often considered contraindications to beta-blockade (such as heart failure, pulmonary disease, and older age) and those with nontransmural infarction benefit from beta-blocker therapy.

Source Information

From the Department of Medicine and the Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore.

Address reprint requests to Dr. Gottlieb at the Division of Cardiology, University of Maryland Medical Systems, 22 S. Greene St., Baltimore, MD 21201.

Full Text of this Article

Related Letters:

Beta-Blockers after Myocardial Infarction
Torp-Pedersen C., Køber L., Gottlieb S. S., McCarter R. J., Vogel R. A.
Extract | Full Text  
N Engl J Med 1998; 339:2022-2023, Dec 31, 1998. Correspondence

Pravastatin and Coronary Heart Disease
Meyer F. P., Bloom J. M., Tonkin A., Hunt D., Simes R. J., The LIPID Study Group
Extract | Full Text  
N Engl J Med 1999; 340:1115-1117, Apr 8, 1999. Correspondence

Observational Studies and Randomized Trials
Kunz R., Khan K. S., Neumayer H.-H., Sacks H. S., Liu P.-Y., Anderson G., Crowley J. J., Friedman H. S., Smith R. P., Meier P., Benson K., Hartz A. J., Concato J., Shah N., Horwitz R. I.
Extract | Full Text  
N Engl J Med 2000; 343:1194-1197, Oct 19, 2000. Correspondence

Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
Bell D. S.H., Gress T. W., Brancati F. L., Sowers J. R., Bakris G. L.
Extract | Full Text  
N Engl J Med 2000; 343:580-581, Aug 24, 2000. Correspondence

This article has been cited by other articles:

• van Gestel, Y. R. B. M., Hoeks, S. E., Sin, D. D., Welten, G. M. J. M., Schouten, O., Witteveen, H. J., Simsek, C., Stam, H., Mertens, F. W., Bax, J. J., van Domburg, R. T., Poldermans, D. (2008). Impact of Cardioselective {beta}-Blockers on Mortality in Patients with Chronic Obstructive Pulmonary Disease and Atherosclerosis. Am. J. Respir. Crit. Care Med. 178: 695-700 [Abstract] [Full Text]  
• Wei, L, Lang, C C, Sullivan, F M, Boyle, P, Wang, J, Pringle, S D, MacDonald, T M (2008). Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study. Heart 94: 1141-1146 [Abstract] [Full Text]  
• Triplitt, C., Alvarez, C. A. (2008). Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes. Diabetes Spectr. 21: 177-189 [Abstract] [Full Text]  
• Matyal, R. (2008). Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management: A Core Review. Anesth. Analg. 107: 37-50 [Abstract] [Full Text]  
• Au, D. H (2008). Use of {beta} blockers in patients with COPD. Thorax 63: 296-298 [Full Text]  
• Dransfield, M T, Rowe, S M, Johnson, J E, Bailey, W C, Gerald, L B (2008). Use of {beta} blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 63: 301-305 [Abstract] [Full Text]  
• van der Elst, M. E, Bouvy, M. L, de Blaey, C. J, de Boer, A. (2007). Effect of drug combinations on admission for recurrent myocardial infarction. Heart 93: 1226-1230 [Abstract] [Full Text]  
• Lee, T. H. (2007). Eulogy for a Quality Measure. NEJM 357: 1175-1177 [Full Text]  
• Bangalore, S., Messerli, F. H., Kostis, J. B., Pepine, C. J. (2007). Cardiovascular Protection Using Beta-Blockers: A Critical Review of the Evidence. J Am Coll Cardiol 50: 563-572 [Abstract] [Full Text]  
• Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Berghe, G. V. d., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J Suppl 9: C3-C74 [Full Text]  
• Mancini, G. B. J. (2007). Clarion Call for Trials Assessing "Cardiopulmonary" Agents To Reduce Morbidity and Mortality in Inflammatory Lung Diseases. Chest 131: 950-951 [Full Text]  
• Jin, Y.-T., Hasebe, N., Matsusaka, T., Natori, S., Ohta, T., Tsuji, S., Kikuchi, K. (2007). Magnesium attenuates isoproterenol-induced acute cardiac dysfunction and beta-adrenergic desensitization. Am. J. Physiol. Heart Circ. Physiol. 292: H1593-H1599 [Abstract] [Full Text]  
• Le Jemtel, T. H., Padeletti, M., Jelic, S. (2007). Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure. J Am Coll Cardiol 49: 171-180 [Abstract] [Full Text]  
• Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28: 88-136 [Full Text]  
• Adesanya, A. O., de Lemos, J. A., Greilich, N. B., Whitten, C. W. (2006). Management of perioperative myocardial infarction in noncardiac surgical patients.. Chest 130: 584-596 [Abstract] [Full Text]  
• Shelton, R J, Rigby, A S, Cleland, J G F, Clark, A L (2006). Effect of a community heart failure clinic on uptake of {beta} blockers by patients with obstructive airways disease and heart failure. Heart 92: 331-336 [Abstract] [Full Text]  
• Nahra, T. A., Reiter, K. L., Hirth, R. A., Shermer, J. E., Wheeler, J. R. C. (2006). Cost-Effectiveness of Hospital Pay-for-Performance Incentives. Med Care Res Rev 63: 49S-72S [Abstract]  
• Bassand, J.-P. (2006). Clinical implications of inhibition of the late sodium current: ranolazine. Eur Heart J Suppl 8: A14-A19 [Abstract] [Full Text]  
• Maser, R. E., Lenhard, M. J. (2005). Cardiovascular Autonomic Neuropathy Due to Diabetes Mellitus: Clinical Manifestations, Consequences, and Treatment. J. Clin. Endocrinol. Metab. 90: 5896-5903 [Abstract] [Full Text]  
• McDonald, C. G., Majumdar, S. R., Mahon, J. L., Johnson, J. A. (2005). The Effectiveness of {beta}-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes. Diabetes Care 28: 2113-2117 [Abstract] [Full Text]  
• Egred, M., Shaw, S., Mohammad, B., Waitt, P., Rodrigues, E. (2005). Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease. QJM 98: 493-497 [Abstract] [Full Text]  
• Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F., Lameire, N., for the European Uremic Toxin Work Group (EUTox), (2005). Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20: 1048-1056 [Abstract] [Full Text]  
• Fox, D J, Kibiro, M, Eichhofer, J, Curzen, N P (2005). Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?. Postgrad. Med. J. 81: 401-403 [Abstract] [Full Text]  
• Jardine, D. L., Charles, C. J., Ashton, R. K., Bennett, S. I., Whitehead, M., Frampton, C. M., Nicholls, M. G. (2005). Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model. J. Physiol. 565: 325-333 [Abstract] [Full Text]  
• Wei, L., Ebrahim, S., Bartlett, C., Davey, P. D, Sullivan, F. M, MacDonald, T. M (2005). Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials. BMJ 330: 821- [Abstract] [Full Text]  
• Weiner, M, Stump, T E, Callahan, C M, Lewis, J N, McDonald, C J (2005). Pursuing integration of performance measures into electronic medical records: beta-adrenergic receptor antagonist medications. Qual Saf Health Care 14: 99-106 [Abstract] [Full Text]  
• Leon, A. S., Franklin, B. A., Costa, F., Balady, G. J., Berra, K. A., Stewart, K. J., Thompson, P. D., Williams, M. A., Lauer, M. S. (2005). Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease: An American Heart Association Scientific Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 111: 369-376 [Abstract] [Full Text]  
• Gluckman, T. J., Sachdev, M., Schulman, S. P., Blumenthal, R. S. (2005). A Simplified Approach to the Management of Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA 293: 349-357 [Abstract] [Full Text]  
• Gatzoulis, K. A., Andrikopoulos, G. K., Apostolopoulos, T., Sotiropoulos, E., Zervopoulos, G., Antoniou, J., Brili, S., Stefanadis, C. I. (2005). Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 7: 184-192 [Abstract] [Full Text]  
• Gupta, R., Birnbaum, Y., Uretsky, B. F. (2004). The renal patient with coronary artery disease: Current concepts and dilemmas. J Am Coll Cardiol 44: 1343-1353 [Abstract] [Full Text]  
• Satwani, S., Dec, G. W., Narula, J. (2004). {beta}-Adrenergic Blockers in Heart Failure: Review of Mechanisms of Action and Clinical Outcomes. J CARDIOVASC PHARMACOL THER 9: 243-255 [Abstract]  
• Anavekar, N. S., McMurray, J. J.V., Velazquez, E. J., Solomon, S. D., Kober, L., Rouleau, J.-L., White, H. D., Nordlander, R., Maggioni, A., Dickstein, K., Zelenkofske, S., Leimberger, J. D., Califf, R. M., Pfeffer, M. A. (2004). Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction. NEJM 351: 1285-1295 [Abstract] [Full Text]  
• Lappe, J. M., Muhlestein, J. B., Lappe, D. L., Badger, R. S., Bair, T. L., Brockman, R., French, T. K., Hofmann, L. C., Horne, B. D., Kralick-Goldberg, S., Nicponski, N., Orton, J. A., Pearson, R. R., Renlund, D. G., Rimmasch, H., Roberts, C., Anderson, J. L. (2004). Improvements in 1-Year Cardiovascular Clinical Outcomes Associated with a Hospital-Based Discharge Medication Program. ANN INTERN MED 141: 446-453 [Abstract] [Full Text]  
• Aguilar, D., Solomon, S. D., Kober, L., Rouleau, J.-L., Skali, H., McMurray, J. J.V., Francis, G. S., Henis, M., O'Connor, C. M., Diaz, R., Belenkov, Y. N., Varshavsky, S., Leimberger, J. D., Velazquez, E. J., Califf, R. M., Pfeffer, M. A. (2004). Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Circulation 110: 1572-1578 [Abstract] [Full Text]  
• Sirak, T. E., Jelic, S., Le Jemtel, T. H. (2004). Therapeutic update: Non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 44: 497-502 [Abstract] [Full Text]  
• Gluckman, T. J., Baranowski, B., Ashen, M. D., Henrikson, C. A., McAllister, M., Braunstein, J. B., Blumenthal, R. S. (2004). A Practical and Evidence-Based Approach to Cardiovascular Disease Risk Reduction. Arch Intern Med 164: 1490-1500 [Abstract] [Full Text]  
• Kernis, S. J., Harjai, K. J., Stone, G. W., Grines, L. L., Boura, J. A., O'Neill, W. W., Grines, C. L. (2004). Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?. J Am Coll Cardiol 43: 1773-1779 [Abstract] [Full Text]  
• Toyo-Oka, T., Kawada, T., Nakata, J., Xie, H., Urabe, M., Masui, F., Ebisawa, T., Tezuka, A., Iwasawa, K., Nakajima, T., Uehara, Y., Kumagai, H., Kostin, S., Schaper, J., Nakazawa, M., Ozawa, K. (2004). Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: A scheme for the progression of cardiac dysfunction. Proc. Natl. Acad. Sci. USA 101: 7381-7385 [Abstract] [Full Text]  
• Ho, P. M., Masoudi, F. A., Peterson, E. D., Grunwald, G. K., Sales, A. E., Hammermeister, K. E., Rumsfeld, J. S. (2004). Cardiology management improves secondary prevention measures among patients with coronary artery disease. J Am Coll Cardiol 43: 1517-1523 [Abstract] [Full Text]  
• Newby, D. E., Nimmo, A. F. (2004). Editorial II: Prevention of cardiac complications of non-cardiac surgery: stenosis and thrombosis. Br J Anaesth 92: 628-632 [Full Text]  
• Camm, A. J., Pratt, C. M., Schwartz, P. J., Al-Khalidi, H. R., Spyt, M. J., Holroyde, M. J., Karam, R., Sonnenblick, E. H., Brum, J. M.G., on Behalf of the AzimiLide post Infarct surVival E, (2004). Mortality in Patients After a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification. Circulation 109: 990-996 [Abstract] [Full Text]  
• Wijeysundera, D. N., Beattie, W. S., Rao, V., Ivanov, J., Karkouti, K. (2004). Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis. J. Thorac. Cardiovasc. Surg. 127: 755-762 [Abstract] [Full Text]  
• Narins, C. R., Zareba, W., Moss, A. J., Marder, V. J., Ridker, P. M., Krone, R. J., Lichstein, E. (2004). Relationship Between Intermittent Claudication, Inflammation, Thrombosis, and Recurrent Cardiac Events Among Survivors of Myocardial Infarction. Arch Intern Med 164: 440-446 [Abstract] [Full Text]  
• Ward, P R, Noyce, P R, St Leger, A S (2004). Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England. J. Epidemiol. Community Health 58: 89-96 [Abstract] [Full Text]  
• Everly, M. J, Heaton, P. C, Cluxton, R. J Jr (2004). {beta}-Blocker Underuse in Secondary Prevention of Myocardial Infarction. The Annals of Pharmacotherapy 38: 286-293 [Abstract] [Full Text]  
• Steinbeck, G., Andresen, D., Senges, J., Hoffmann, E., Seidl, K., Brachmann, J., for the IRIS investigators as Joint Study of the G, (2004). Immediate Risk-Stratification Improves Survival (IRIS): study protocol. Europace 6: 392-399 [Abstract] [Full Text]  
• Andrus, M. R, Holloway, K. P, Clark, D. B (2004). Use of {beta}-Blockers in Patients with COPD. The Annals of Pharmacotherapy 38: 142-145 [Abstract] [Full Text]  
• Sadeghi, H. M., Stone, G. W., Grines, C. L., Mehran, R., Dixon, S. R., Lansky, A. J., Fahy, M., Cox, D. A., Garcia, E., Tcheng, J. E., Griffin, J. J., Stuckey, T. D., Turco, M., Carroll, J. D. (2003). Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction. Circulation 108: 2769-2775 [Abstract] [Full Text]  
• Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L. Jr, Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T. Jr, Roccella, E. J., the National High Blood Pressure Education Program, (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252 [Abstract] [Full Text]  
• Hurst, R. T., Lee, R. W. (2003). Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management. ANN INTERN MED 139: 824-834 [Abstract] [Full Text]  
• Johnson, D., Jin, Y., Quan, H., Cujec, B. (2003). Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol 42: 1438-1445 [Abstract] [Full Text]  
• Silvet, H., Spencer, F., Yarzebski, J., Lessard, D., Gore, J. M., Goldberg, R. J. (2003). Communitywide Trends in the Use and Outcomes Associated With {beta}-Blockers in Patients With Acute Myocardial Infarction: The Worcester Heart Attack Study. Arch Intern Med 163: 2175-2183 [Abstract] [Full Text]  
• van der Elst, M. E, Buurma, H., Bouvy, M. L, de Boer, A. (2003). Drug Therapy for Prevention of Recurrent Myocardial Infarction. The Annals of Pharmacotherapy 37: 1465-1477 [Abstract] [Full Text]  
• Prasad, A., Mathew, V., Holmes, D. R Jr., Gersh, B. J (2003). Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials. Eur Heart J 24: 1544-1553 [Abstract] [Full Text]  
• Santopinto, J J, Fox, K A A, Goldberg, R J, Budaj, A, Pinero, G, Avezum, A, Gulba, D, Esteban, J, Gore, J M, Johnson, J, Gurfinkel, E P (2003). Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 89: 1003-1008 [Abstract] [Full Text]  
• Koerbel, G., Korytkowski, M. (2003). Coronary Heart Disease in Women With Diabetes. Diabetes Spectr. 16: 148-153 [Abstract] [Full Text]  
• Tangeman, H. J, Patterson, J H. (2003). Extended-Release Metoprolol Succinate in Chronic Heart Failure. The Annals of Pharmacotherapy 37: 701-710 [Abstract] [Full Text]  
• Gheorghiade, M., Colucci, W. S., Swedberg, K. (2003). {beta}-Blockers in Chronic Heart Failure. Circulation 107: 1570-1575 [Full Text]  
• Kuhlkamp, V., Seipel, L., Healy, E. C., Bhaskarabhatla, K., Manning, W. J., Wyse, D. G., Van Gelder, I. C., Crijns, H. J.G.M. (2003). Atrial Fibrillation -- Rate versus Rhythm Control. NEJM 348: 1284-1286 [Full Text]  
• Douglas, J. G., Bakris, G. L., Epstein, M., Ferdinand, K. C., Ferrario, C., Flack, J. M., Jamerson, K. A., Jones, W. E., Haywood, J., Maxey, R., Ofili, E. O., Saunders, E., Schiffrin, E. L., Sica, D. A., Sowers, J. R., Vidt, D. G., the Hypertension in African Americans Working Grou, (2003). Management of High Blood Pressure in African Americans: Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163: 525-541 [Full Text]  
• SCOTT, I. A., HEATH, K., HARPER, C., CLOUGH, A. (2003). An Australian comparison of specialist care of acute myocardial infarction. Int J Qual Health Care 15: 155-161 [Abstract] [Full Text]  
• Vittinghoff, E., Shlipak, M. G., Varosy, P. D., Furberg, C. D., Ireland, C. C., Khan, S. S., Blumenthal, R., Barrett-Connor, E., Hulley, S., for the Heart and Estrogen/progestin Replacement S, (2003). Risk Factors and Secondary Prevention in Women with Heart Disease: The Heart and Estrogen/progestin Replacement Study. ANN INTERN MED 138: 81-89 [Abstract] [Full Text]  
• Williams, I. L, Vazir, A., Zaman, A. G (2003). Review: The management of stable angina in diabetes. British Journal of Diabetes & Vascular Disease 3: 18-25 [Abstract]  
• ten Broecke, P. W. C., De Hert, S. G., Mertens, E., Adriaensen, H. F. (2003). Effect of preoperative {beta}-blockade on perioperative mortality in coronary surgery. Br J Anaesth 90: 27-31 [Abstract] [Full Text]  
• Butler, J., Arbogast, P. G., BeLue, R., Daugherty, J., Jain, M. K., Ray, W. A., Griffin, M. R. (2002). Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol 40: 1589-1595 [Abstract] [Full Text]  
• Salpeter, S. R., Ormiston, T. M., Salpeter, E. E. (2002). Cardioselective {beta}-Blockers in Patients with Reactive Airway Disease: A Meta-Analysis. ANN INTERN MED 137: 715-725 [Abstract] [Full Text]  
• Chyun, D., Vaccarino, V., Murillo, J., Young, L. H., Krumholz, H. M. (2002). Cardiac Outcomes After Myocardial Infarction in Elderly Patients With Diabetes Mellitus. Am J Crit Care 11: 504-519 [Abstract] [Full Text]  
• Geraci, S. A., Haan, C. K. (2002). Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature?. Ann. Thorac. Surg. 74: 1727-1732 [Abstract] [Full Text]  
• Chassot, P.-G., Delabays, A., Spahn, D. R. (2002). Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Br J Anaesth 89: 747-759 [Abstract] [Full Text]  
• Burjorjee, J. E., Milne, B. (2002). Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol: [Le propofol et la tempete electrique; l'observation d'un cas de cardioversion et de suppression de la tachycardie ventriculaire par le propofol]. Canadian J. Anesthesia 49: 973-977 [Abstract] [Full Text]  
• Wu, A. H., Parsons, L., Every, N. R., Bates, E. R. (2002). Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 40: 1389-1394 [Abstract] [Full Text]  
• Underwood, P, Beck, P (2002). Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues. Qual Saf Health Care 11: 230-232 [Abstract] [Full Text]  
• Wei, L, Wang, J, Thompson, P, Wong, S, Struthers, A D, MacDonald, T M (2002). Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 88: 229-233 [Abstract] [Full Text]  
• Marso, S. P. (2002). Optimizing the diabetic formulary: beyond aspirin and insulin. J Am Coll Cardiol 40: 652-661 [Abstract] [Full Text]  
• Keeble, W, Cobbe, S M (2002). Patient recall of medication details in the outpatient clinic. Audit and assessment of the value of printed instructions requesting patients to bring medications to clinic. Postgrad. Med. J. 78: 479-482 [Abstract] [Full Text]  
• Gheorghiade, M., Goldstein, S. (2002). {beta}-Blockers in the Post-Myocardial Infarction Patient. Circulation 106: 394-398 [Full Text]  
• Grundy, S. M. (2002). Statin Therapy in Older Persons: Pertinent Issues. Arch Intern Med 162: 1329-1331 [Full Text]  
• Goldberg, I, Anton, A, Skuta, G L, Goldberg, I (2002). Should {beta} blockers be abandoned as initial monotherapy in chronic open angle glaucoma? The controversy. Br. J. Ophthalmol. 86: 691-695 [Full Text]  
• Ferguson, T. B. Jr, Coombs, L. P., Peterson, E. D., for the Society of Thoracic Surgeons National Adul, (2002). Preoperative {beta}-Blocker Use and Mortality and Morbidity Following CABG Surgery in North America. JAMA 287: 2221-2227 [Abstract] [Full Text]  
• Wheeler, D. C (2002). Protecting the kidneys and cardiovascular system in type 2 diabetes. British Journal of Diabetes & Vascular Disease 2: 77-79  
• Farrell, M. H., Foody, J. M., Krumholz, H. M. (2002). {beta}-Blockers in Heart Failure: Clinical Applications. JAMA 287: 890-897 [Abstract] [Full Text]  
• Zaugg, M., Schaub, M. C., Pasch, T., Spahn, D. R. (2002). Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth 88: 101-123 [Abstract] [Full Text]  
• Malliani, A., Montano, N. (2002). Emerging Excitatory Role of Cardiovascular Sympathetic Afferents in Pathophysiological Conditions. Hypertension 39: 63-68 [Abstract] [Full Text]  
• Petersen, L. A., Normand, S.-L. T., Leape, L. L., McNeil, B. J. (2001). Comparison of Use of Medications After Acute Myocardial Infarction in the Veterans Health Administration and Medicare. Circulation 104: 2898-2904 [Abstract] [Full Text]  
• Ruilope, L. M., van Veldhuisen, D. J., Ritz, E., Luscher, T. F. (2001). Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 38: 1782-1787 [Abstract] [Full Text]  
• Huikuri, H. V., Castellanos, A., Myerburg, R. J. (2001). Sudden Death Due to Cardiac Arrhythmias. NEJM 345: 1473-1482 [Full Text]  
• Giugliano, R.P, Llevadot, J, Wilcox, R.G, Gurfinkel, E.P, McCabe, C.H, Charlesworth, A, Thompson, S.L, Antman, E.M, Braunwald, E, for the In TIME II Investigators, (2001). Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J 22: 1702-1715 [Abstract]  
• Priori, S.G., Aliot, E., Blomstrom-Lundqvist, C., Bossaert, L., Breithardt, G., Brugada, P., Camm, A.J., Cappato, R., Cobbe, S.M., Di Mario, C., Maron, B.J., McKenna, W.J., Pedersen, A.K., Ravens, U., Schwartz, P.J., Trusz-Gluza, M., Vardas, P., Wellens, H.J.J., Zipes, D.P. (2001). Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22: 1374-1450  
• Prichard, B.N.C., Robin, J.M. (2001). Beta-blockade and surgery. Eur Heart J 22: 1253-1255 [Abstract]  
• Abdulla, J, Brendorp, B, Torp-Pedersen, C, Kober, L, on behalf of the TRACE study group, (2001). Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction?. Eur Heart J 22: 1008-1014 [Abstract]  
• Elsner, D. (2001). How to diagnose and treat coronary artery disease in the uraemic patient: an update. Nephrol Dial Transplant 16: 1103-1108 [Full Text]  
• Singh, B. N. (2001). CIBIS, MERIT-HF, and COPERNICUS Trial Outcomes: Do They Complete the Chapter on -Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Drugs?. J CARDIOVASC PHARMACOL THER 6: 107-110  
• Chen, J., Radford, M. J., Wang, Y., Marciniak, T. A., Krumholz, H. M. (2001). Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol 37: 1950-1956 [Abstract] [Full Text]  
• The IONA Study Group, (2001). Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management. Heart 85: 9e-9 [Abstract] [Full Text]  
• Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. J., Krumholz, H. M. (2001). Quality of Medical Care and Excess Mortality in Older Patients With Mental Disorders. Arch Gen Psychiatry 58: 565-572 [Abstract] [Full Text]  
• Myerburg, R. J, Spooner, P. M (2001). Opportunities for sudden death prevention: Directions for new clinical and basic research. Cardiovasc Res 50: 177-185 [Abstract] [Full Text]  
• (2001). Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22: 554-572 [Abstract]  
• Salvi, S. (2001). Protecting the Myocardium From Ischemic Injury : A Critical Role for {{alpha}}1-Adrenoreceptors?. Chest 119: 1242-1249 [Abstract] [Full Text]